This refresher will highlight existing standards of care in pediatric radiation oncology, review recent updates to the standard of care, comment on new radiation techniques unique to pediatric radiation oncology, and discuss some of the current controversies in the application of radiotherapy in

This refresher will highlight existing standards of care in pediatric radiation oncology, review recent updates to the standard of care, comment on new radiation techniques unique to pediatric radiation oncology, and discuss some of the current controversies in the application of radiotherapy in

This is a lecture-based educational format designed to update attendees on the latest evidence-based practice recommendations for head and neck cancer radiation therapy.

This is a lecture-based educational format designed to update attendees on the latest evidence-based practice recommendations for head and neck cancer radiation therapy.

The session will review the current clinical management of the most common malignant and benign adult CNS tumors. This review will provide an overview of the current clinical practice in the treatment of brain metastases.

The session will review the current clinical management of the most common malignant and benign adult CNS tumors. This review will provide an overview of the current clinical practice in the treatment of brain metastases.

This presentation will help inform listeners about the multidisciplinary care of patients with lymphoma, the use of contemporary treatment fields (e.g. INRT, ISRT), appropriate use of technology (i.e.

This presentation will help inform listeners about the multidisciplinary care of patients with lymphoma, the use of contemporary treatment fields (e.g. INRT, ISRT), appropriate use of technology (i.e.

In this course, we provide an overview of biomarker definitions and potential use in the management of cancer patients.  We then describe the historical evolution of efforts by NRG Oncology to develop and validate tissue-based molecular biomarkers to direct management of GU cancers treated with r

In this course, we provide an overview of biomarker definitions and potential use in the management of cancer patients.  We then describe the historical evolution of efforts by NRG Oncology to develop and validate tissue-based molecular biomarkers to direct management of GU cancers treated with r